here press releas huntington medic research institut . 
new method for diagnos alzheim 's diseas discov huntington medic research institut result be report to nation desk health writer contact john lockhart belinda gerber 310-444-7000 800-522-8877 huntington medic research institut . 
los angel april 28 a new method diagnos measur chemic imbal brain lead alzheim 's diseas dementia discov research huntington medic research institut hmri pasadena calif . 
result research report may issu scientif journal radiolog . 
use advanc form magnet reson imag mri call magnet reson spectroscopi mrs research team led brian d . 
ross m.d . 
d . 
phil . 
conduct studi 21 elder patient believ suffer form dementia . 
the exam use standard mri equip fit special softwar develop hmri call clinic proton mrs . 
clinic proton mrs easili appli give doctor confirmatori diagnos less 30 minut . 
an autom version clinic proton mrs call proton brain examin probe reduc examin time yet provid confirmatori diagnos less 10 minut . 
by comparison current standard care test alzheim 's diseas call lengthi memori function neuropsycholog test upset patient definit confirm autopsi . 
in addit alzheim 's diseas new clinic proton mrs exam may applic diagnos dementia includ aids-rel dementia parkinson 's diseas huntington 's diseas . 
we ve develop simpl test administ quick relat inexpens use exist mri equip fit either mrs probe softwar said dr . 
ross ad help physician diagnos alzheim 's earlier interven therapeut progress diseas caus damag delic inner work brain dr . 
ross hmri team measur famili chemic brain known inositol myo-inositol mi act marker studi . 
in comparison healthi patient diagnos alzheim 's show 22 percent increas mi level anoth chemic call n-acetylaspart naa signific lower indic loss brain-stimul neuron believ associ progress diseas . 
current drug therapi alzheim 's diseas wide consid inadequ . 
this attribut dr . 
ross believ theori alzheim 's caus interrupt transmiss chemic acetylcholin nerv cell . 
this belief adher last 15 year consequ drug treat alzheim 's base chang receptor acetylcholin . 
physician real need test differenti alzheim 's dementia provid patient famili firm diagnosi monitor futur treatment protocol treatment diseas . 
for reason consid test major advanc medicin said bruce miller m.d . 
note neurologist harbor-ucla mrs research co-author studi . 
other member hmri research team includ rex a . 
moat ph.d . 
truda shonk b.s . 
thoma ernst ph.d . 
suzann woolley r.n . 
the probe softwar fit approxim 1200 general electr mri unit current use unit state configur manufactur ' mri unit soon . 
for interview dr . 
ross advanc copi radiolog may issu inform pleas contact john lockhart belinda gerber hmri 310-444-7000 800-522-8877 . 
q a alzheim 's diseas what alzheim 's diseas caus ? 
alzheim 's diseas ad incur degen diseas brain first describ 1906 german neuropathologist aloi alzheim . 
as diseas progress lead loss memori mental function follow chang person loss control bodili function eventu death . 
how mani peopl affect ? 
alzheim 's diseas affect estim 4 million adult unit state fourth lead caus death take approxim 100000 live year . 
while alzheim 's debilit victim equal devast emot financi patient ' famili . 
ad common caus dementia adult . 
symptom worsen everi year death usual occur within 10 year initi onset . 
what sign symptom ? 
although caus ad known two risk factor identifi advanc age genet predisposit . 
the risk develop ad less one percent age 50 yar old increas steepli success decad life reach 30 percent age 90 . 
in patient famili ad immedi famili relat 50 percent chanc develop ad . 
one first symptom sever forget caus short-term memori loss . 
dr . 
herman weinreb school medicin new york univers say whether forget serious symptom larg matter degre suggest follow criteria forget name someon see infrequ normal . 
forget name love one serious . 
forget left key normal . 
forget get home serious . 
doctor suggest peopl sever symptom evalu order rule alzheim 's diseas form dementia . 
-30- 
